The hypoxic conditions and oncogenic molecules in tumor cells cause upregulation of the expression of the receptor for glucose internalization, GLUT1, in addition to other genes of metabolism.87,88 As a result, tumors undergoing immune reprogramming with increased import-receptor expression outcompete immune cells for glucose. The gene discussed is SLC2A1; the disease is neoplasm.